Mark W. Sawicki, Ph.D.
About Mark W. Sawicki, Ph.D.
Mark W. Sawicki, Ph.D. - President & CEO
Mark W. Sawicki, Ph.D., currently serves as the President and CEO. He has an extensive background in biochemistry, having earned both his bachelor's degree and Ph.D. from the State University of New York at Buffalo. His role as President and CEO speaks to his strong leadership and comprehensive knowledge in the field.
Mark Sawicki's Education and Expertise
Mark W. Sawicki holds a bachelor's degree in biochemistry from the State University of New York at Buffalo. He went on to earn his Ph.D. in biochemistry from the same institution's School of Medicine and Biomedical Sciences. His academic training includes graduate work at the Hauptman Woodard Medical Research Institute, cementing a robust foundation in biochemistry, particularly in drug discovery, oncology, and immunology.
Mark Sawicki's Publications in Drug Discovery
Dr. Mark W. Sawicki has authored a dozen scientific publications primarily focused on drug discovery, with a particular emphasis on oncology and immunology. His contributions to scientific literature demonstrate his deep expertise and ongoing commitment to advancing research in these critical fields.
Mark Sawicki's Professional Background
Before his current role as President and CEO, Mark W. Sawicki served as the Chief Business Officer at AAIPharma Services Corporation/Cambridge Major Laboratories Inc. He has also held senior business development roles at CMC Biologics and Albany Molecular Research Inc. (AMRI). His professional experience spans several high-level business development positions, underscoring his capabilities in leading and managing complex initiatives within the biochemistry and pharmaceuticals sectors.